Alexey V. Vasilyiev

Alexey V. Vasilyiev

Auto-generated profile, based on publicly available information

Alexey V. Vasilyiev

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2024 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
ILIgor S. Lebedev
Igor S. Lebedev
AVAlexey V. Vasilyev
Alexey V. Vasilyev
DCDmitry A. Churikov
Dmitry A. Churikov
NMNadezhda Yu Mishakina
Nadezhda Yu Mishakina
AAAlexander V. Alenichev
Alexander V. Alenichev
Purpose: To develop a strategy for the iliac vein stenting in patients with a combination of the left common iliac vein (LCIV) compression stenosis and pelvic venous insufficiency (PVI). Methods: This prospective comparative cohort study included 55 patients with hemodynamically significant LCIV stenosis out of 285 females with PVI screened in 2014–2022. All 55 patients underwent duplex ultrasound, multi-detector computed venography, ovarian venography, and multiplanar pelvic venography. Patients underwent LCIV stenting or the left gonadal vein (LGV) embolization as the primary intervention. The endpoints (chronic pelvic pain [CPP] relief, patency of stents, and reduction in pelvic venous reflux [PVR]) were evaluated 1 and 10 days, as well as 1, 6, and 12 months after the procedure. All patients received antithrombotic therapy after the interventions. Results: The primary LCIV stenting was performed in 49 patients and resulted in the CPP relief in 69.4%, pain reduction from 7.9±1.3 to 1.7±1.1 visual analog scale (VAS) scores (p=0.005), and substantial reduction of PVR in LGV (from 4.3±0.6 seconds to 1.9±0.3 seconds, p=0.003). The LGV embolization as the second stage of treatment was performed in 30.6% of patients with the LGV reflux greater than 5 seconds as a possible cause for the CPP persistence. The primary LGV embolization failed in 100% of patients (no changes in CPP and PVR). The LCIV stenting at the second stage resulted in the CPP relief within 10 days and the pelvic venous reflux (PVR) reduction. There were no complications of stenting, and the patency of stents in the follow-up period was 100%. Postembolization syndrome occurred in 9.5% of patients. No thromboses of the veins of the pelvis and lower extremities were identified. Conclusion: Treatment of patients with a combination of LCIV compression and PVI involves staged endovascular interventions: the LCIV stenting should be considered the first-line treatment, while the LGV embolization is performed when the PVI symptoms persist for more than 6 months and is not acceptable as the first-line treatment. Clinical Impact: The developed strategy of endovascular treatment for the combination of left common iliac vein (LCIV) and pelvic venous insufficiency (PVI) provides an effective elimination of chronic pelvic pain (CPP) and reflux in the pelvic veins and avoids unnecessary embolizations of the gonadal veins, thereby eliminating possible risks related to complications of embolization. The use of antithrombotic therapy is an effective and safe approach for preventing venous thromboembolic events after endovascular interventions.

23 April 2023 in Journal of Venous Disorders
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
ILI.S. Lebedev
I.S. Lebedev
AVA.V. Vasiliev
A.V. Vasiliev
NMN.YU. Mishakina
N.YU. Mishakina
Considering literature and clinical data, the authors present the arguments in favor of stenting in patients with chronic venous obstructions. Modern literature devoted to stenting for chronic thrombotic and non-thrombotic obstruction of iliac veins was analyzed. Currently, classical and special venous stents are used for iliac vein stenting. The latter have greater flexibility and radial strength. They are not accompanied by such complications as stent-related occlusion of contralateral common iliac vein and cone-shaped narrowing of both ends of the stent. Literature data indicate high efficiency of stenting for recanalization of iliac veins in patients with thrombotic and non-thrombotic iliac vein obstructions. Stent patency varies from 79 to 100% within 1—3 years. Relief of edematous and pain syndrome, as well as healing of trophic ulcer occurs in 70—100% of patients. Comparison of the cost of venous stenting and standard therapy indicates that endovascular intervention is accompanied by significantly lower treatment cost and less period of temporary disability. Clinical examples demonstrate the possibilities of iliac vein stenting in patients with post-thrombotic disease, combination of May-Thurner syndrome and pelvic venous congestion. Venous stenting is effective and safe for recanalization of great veins, correction of chronic venous insufficiency and pelvic venous congestion syndrome. This approach reduces treatment cost in patients with chronic venous obstructions.

26 March 2026 in Journal of Venous Disorders
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
AVA.V. Vasilyev
A.V. Vasilyev
SCS.V. Chubchenko
S.V. Chubchenko
Objective. To evaluate the economic costs of treating patients with a combination of left common iliac vein compression stenosis (LCIVCS) and pelvic venous insufficiency (PVI) using various endovascular techniques considering their clinical effectiveness. Material and methods. This retrospective cohort comparative study included 55 patients with hemodynamically significant LCIVCS and PVI. Primary stenting of the left common iliac vein (LCIV) was performed in 49 patients (Group 1), and primary left-sided ovarian vein embolization (OVE) was used in 6 patients (Group 2). The clinical outcome of primary stenting of the LCIV and OVE was assessed by recording the dynamics of chronic pelvic pain (CPP) using visual analogue scale (VAS) 10 days, 1, 3 and 6 months after the interventions. The financial costs of stenting of the LCIV, OVE and combined use of these two treatment methods were assessed individually. Results. After stenting of the LCIV, a significant reduction or complete resolution of chronic pelvic pain (before treatment: 8 [7—9] points; after 6 months: 1 [0—2] point; p=0.005) was noted in 69.4% of patients. The clinical effect of stenting was insignificant in 30.6% of patients and they underwent OVE. After primary OVE, no positive clinical effect was observed in 100% of cases, CPP persisted (before treatment: 7 [5—9] points; after 6 months: 7 [6—9] points; p=0.73). These patients underwent stenting of the LCIV, which was accompanied by a significant reduction in CPP. The personalized cost of treatment in the 1st group was 220 666.97 rubles, in the second — 316 517.46 rubles; when using primary stenting of the LCIV, the cost savings for the treatment of one patient amounted to 43.6%. Conclusions. Primary stenting of the LCIV in patients with a combination of the LCIVCS and PVI is the optimal treatment strategy in terms of clinical effectiveness and economic feasibility. The clinical effectiveness of isolated LCIV stenting is 69.4%, and financial savings — 43.6%.

27 September 2025 in Journal of Venous Disorders
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
VVV.N. Vinogradov
V.N. Vinogradov
AVA.V. Vasilyev
A.V. Vasilyev
SCS.V. Chubchenko
S.V. Chubchenko
EME.P. Moskalenko
E.P. Moskalenko
AGA.S. Grishenkova
A.S. Grishenkova
Objective. To determine hemodynamic significance of the left common iliac vein compression (CIVC) considering clinical, ultrasound, and X-ray venographic data. Material and methods. A total of 110 symptomatic and asymptomatic patients with left-sided CIVC were included in a single-center crossover study. Doppler ultrasound was performed in all patients to determine maximum blood flow velocity (MFV) in poststenotic (MFVpoststenotic) and prestenotic (MFVprestenotic) segments, presence and duration of reflux in pelvic veins. CT venography was performed in all patients to evaluate narrowing and pancaking of the left CIV. Multiplanar pelvic venography was performed in 87 symptomatic patients to assess narrowing of the left CIV, width of pancaking and collateral blood flow through the pelvic veins. Results. Hemodynamically significant left-sided CIVC is always accompanied by symptoms of pelvic venous insufficiency (PVI). Any left-sided CIVC is insignificant a priori without PVI signs. Ultrasound criteria of significant CIVC included MFVpoststenotic/MFVprestenotic>2.5 and duration of pelvic venous reflux >2 seconds. CT sign of severe CIVC was CIV stenosis >50%. CT venography revealed no differences in signs of significant CIVC between symptomatic and asymptomatic patients. Multiplanar pelvic venography revealed hemodynamically significant CIVC in 56.3% of symptomatic patients. It was characterized by pancaking of the left CIV > 20 mm, width of the left CIV exceeding the right one by 30% or more and collateral blood flow in the pelvis without Valsalva maneuver. No correlation was found between severity of narrowing of the left CIV and significant left-sided CIVC. Concordance of Doppler ultrasound and multiplanar pelvic venography in identifying significant left-sided CIVC was 48.9%, CT venography and multiplanar pelvic venography — 59.2%. Conclusions. Stenosis of left CIV is not the main criterion for hemodynamic significance of left-sided CIVC and does not influence the symptoms of PVI. Clinical manifestations of left-sided CIVC are due to reflux in pelvic veins lasting >2 seconds. MPV is the most accurate method for analysis of hemodynamic significance of left-sided CIVC.

26 March 2026 in Journal of Venous Disorders
Verified
Journal Article
Closed access
AKA.S. Kuperin
A.S. Kuperin
ESE.I. Seliverstov
E.I. Seliverstov
AVA.V. Vasilyev
A.V. Vasilyev
EAE.S. An
E.S. An
NBN.A. Babakova
N.A. Babakova
ILI.S. Lebedev
I.S. Lebedev
The article presents a case of treatment proximal deep venous thrombosis using different endovascular approaches. The case emphasizes the importance of individualized approach, monitoring and multidisciplinary management of patients undergoing invasive treatment of deep vein thrombosis (DVT). Patient of 42 years old came with complaints of swelling and bursting pain in the left lower limb lasting 7 days. Iliofemoral venous thrombosis of the left lower limb was confirmed. The patient underwent successful aspiration thrombectomy with subsequent balloon angioplasty. The patient developed re-thrombosis with thrombus extension to the inferior vena cava despite the initial satisfactory outcome of intervention. An inferior vena cava filter was inserted and catheter-directed thrombolysis was performed, which allowed to achieve a good technical result. Attempts of inferior vena cava filter removing in the clinic were unsuccessful and it was successfully excised only in 5 months in another hospital. No DVT recurrence were observed during 12 months of follow-up. The severity of post-thrombotic syndrome was 3 points according to the Villalta scale one year after the treatment. Due to timely diagnosis and comprehensive treatment we achieved stable venous recanalization with favorable long-term outcomes. This case suggests that using only mechanical methods of thrombus extraction without catheter-directed thrombolysis is possible only in case of complete removing ofthrombotic masses.

20 May 2026 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
AVA.V. Vasiliev
A.V. Vasiliev
EAE.A. Antipov
E.A. Antipov
EAE.S. An
E.S. An
MTM.I. Tsarev
M.I. Tsarev
AАAnastasia Аnderzhanova
Anastasia Аnderzhanova
MLM.V. Lukina
M.V. Lukina
Objective. To analyze effectiveness and safety of transcatheter arterial embolization for the treatment of upper gastrointestinal bleeding and compare these results with national and international data. Material and methods. A retrospective analysis of local database included patients with gastroduodenal bleeding for the period from 08.2022 to 12.2024. There were 48 patients including 28 (58.3%) men and 20 (41.6%) women. Mean age of patients was 67.9±11.4 years. Own results were compared with national and international data. Results. There were the following causes of bleeding: various gastric and duodenal tumors — 30 (62.5%); acute and chronic gastric and duodenal ulcers — 16 (33.3%); erosive gastritis, esophagitis — 3 (6.25%). Primary inefficiency of endoscopic hemostasis was noted in 7 patients. In other 41 patients, endoscopic hemostasis was effective. Technical success rate was 100% (48 patients). Recurrence of bleeding was observed in 2 (4%) patients after 2 and 11 days. There was 1 complication (shoulder hematoma without necessary surgical correction). Mean hospital-stay was 15 days. Mortality rate was 33.3% (n=16); 32 (66.7%) patients were discharged. Conclusion. Transcatheter arterial embolization is a quick, safe and effective minimally invasive alternative to surgery, when endoscopic treatment does not allow upper gastrointestinal bleeding control. The advantages of arterial embolization are feasibility of this method in high risk patients, combination of diagnostic angiography to identify the cause of bleeding, rapid hemostasis compared to other instrumental methods.